GREY:ATBPF - Post by User
Comment by
GameChangerBeton Jun 25, 2021 3:10pm
219 Views
Post# 33451674
RE:RE:RE:RE:RE:RE:Dalriada
RE:RE:RE:RE:RE:RE:DalriadaThe currect cash on hand is said to cover Phase III, but keep in mind of the high probability of a deal being reached at some point between now and then, which will come with some type of upfront cash payment as part of the deal.
So yes, current cash is $70m +/- but you can include with some relative assumptions that they will be getting a cash infusion at some point before Phase III completion, further strengthening their position as they move forward.
Straylight wrote: I believe in some of the previous conference calls Dan mentioned that they could move several other drug candidates along for about $1-2m. Of course that is a high level answer and that was probably before they got serious into negotiations for this contract.
Now how drugs this covers, how far it takes them, what the contract value is; all things that we don't have the exact answer to.
Personally I feel that knowing we still have roughly $65m-$70m left for P3, I feel pretty good about this. It keeps a lot of irons in the fire while preserving the bulk of our funds for Otena for P3. I think that puts us into an even better negotiating position for big pharma because it shows we could potentially strike gold with our other candidates and we aren't resting on our laurels with just one drug.